Skip to main content

Smith & Nephew Snats ADR(SNN-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

New evidence demonstrates Smith+Nephew's COBLATION™ Technology can accelerate patient recovery with fewer complications compared with total tonsillectomy techniques

PR Newswire - Thu Mar 23, 2023

LONDON, March 23, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces results from new scientific research that shows its COBLATION Intracapsular Tonsillectomy (CIT) technique can lead to improved post-operative outcomes in patients versus total tonsillectomy techniques. The research was recently published online by OTO Open: The Open Access Journal of the American Academy of Otolaryngology-Head and Neck Surgery Foundation.

Read more at prnewswire.com

Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe